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ABSTRACT 
Environmental (little outdoor light; low indoor lighting) and age-related physiological factors (reduced light 
transmission through the ocular lens, reduced mobility) contribute to a light-deprived environment for older 
people living in care homes. This study investigates the effect of increasing indoor light levels with blue-
enriched white lighting on objective (rest-activity rhythms, performance) and self-reported (mood, sleep, 
alertness) measures in older people. Eighty residents (69 female), aged 86 ± 8 yrs (mean ± SD), participated 
(MMSE 19 ± 6). Overhead fluorescent lighting was installed in communal rooms (n=20) of seven care homes. 
Four weeks of blue-enriched white lighting (17000 K  900 lux) were compared with four weeks of control 
white lighting (4000 K  200 lux), separated by three weeks wash-out. Participants completed validated mood 
and sleep questionnaires, psychomotor vigilance task (PVT) and wore activity and light monitors (AWL). Rest-
activity rhythms were assessed by cosinor, non-parametric circadian rhythm (NPCRA) and actigraphic sleep 
analysis. Blue-enriched (17000 K) light increased wake time and activity during sleep decreasing actual sleep 
time, sleep percentage and sleep efficiency (p < 0.05) (actigraphic sleep). Compared to 4000 K lighting, blue-
enriched 17000 K lighting significantly (p < 0.05) advanced the timing of participants’ rest-activity rhythm 
(cosinor), increased daytime and night-time activity (NPCRA), reduced subjective anxiety (HADA) and sleep 
quality (PSQI). There was no difference between the two light conditions in daytime alertness and performance 
(PVT). Blue-enriched lighting produced some positive (increased daytime activity, reduced anxiety) and 
negative (increased night-time activity, reduced sleep efficiency and quality) effects in older people. 
 
Keywords: care home, light therapy; mood; elderly; rest-activity; sleep. 
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Graphical Abstract 
 
 
The effect of blue-enriched 17000 K lighting (right) on the rest-activity, sleep and mood of older people living 
in care homes has been investigated compared to control 4000 K lighting (middle) (left, original lighting)  
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1. Introduction 
Age-related changes in sleep are widely reported in the literature [1-3]. Increasing age is associated with a 
decrease in sleep efficiency [4], early morning awakening [5; 6], nocturnal awakenings [1 ] and increased sleep 
latency [7]. Poor sleep in older people has been linked to cognitive decline [8], an increase in falls [9] and 
poorer physical and mental health [10] with a significant correlation between cognitive ratings and sleep 
fragmentation [11]. Sleep changes may be due to any number of factors including age-related effects on the 
homeostatic and/or circadian regulation of sleep [12-14]. 
 
Circadian systems are influenced by light and light exposure at set times can shift the timing of circadian 
rhythms [15] and increase circadian amplitude in older people [16] . Increased light levels have been shown to 
increase total sleep time [17] and to improve both alertness and mood at night and during the day [18; 19]. Non-
visual effects of light on behaviour and physiology are dependent on its timing, duration, intensity and 
wavelength [15; 20-22], with short wavelength blue light (420 – 460 nm) having the greatest effect [22-25]. 
Short wavelength light has been shown to reduce accumulated sleep pressure and this effect was seen at light 
levels as low as 40 lux [26]. This blue-light sensitivity has led to the recent development and testing of both blue 
light and blue-enriched polychromatic light in a variety of populations [27-30].  
 
Age-related ocular changes (reduced pupil size; accumulation of crystalline aggregates and light absorbing 
yellow chromophores in the lens) lead to a reduction in the amount of light, specifically short wavelength blue 
light, reaching the retina [31]. There is also a reduction in the classical photoreceptors, rods, S-cones and 
melanopsin photoreceptors with age [32; 33]. Controlled laboratory studies have shown that older people have a 
reduced responsiveness to light [22; 34], especially short wavelength blue light in some [22; 35] but not all 
studies [22; 36]. Therefore increasing the amount of blue light, e.g. using blue-enriched high colour temperature 
polychromatic lighting, may compensate for the reduced responsiveness to short wavelength light observed in 
older people. 
Previous research into increasing light levels in residential care homes has shown a strengthening of the rest-
activity rhythm and better sleep in older people [17; 37-38]. However, these studies have focused primarily on 
dementia sufferers with greater effects observed when combined with melatonin [38]. By contrast, some studies 
have seen little effect of light therapy on sleep of demented care home residents [39-42]. Bright light has also 
been shown to improve the sleep and cognitive performance of older people living in the community not 
suffering from dementia [43]. The 2002 Cochrane review [44] stated that there was an absence of light research 
in the area of older people not suffering from dementia. Light intervention has not, to our knowledge, been 
tested in older people without diagnosed dementia living in care home facilities. 
 
The aim of the current study was to compare the effects of high colour temperature (17000 K) blue-enriched 
white light with low colour temperature (4000 K) white light on older peoples’ subjective mood and alertness 
and objective rest-activity rhythms and sleep. It was hypothesised that the higher intensity blue-enriched 17000 
K light (≈ 900 lux) would have a greater effect than the control 4000 K light (≈ 200 lux) condition. 
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2. Material and Methods 
A favourable ethical opinion was obtained from the University of Surrey Ethics Committee and the care homes, 
whilst all research was carried out according to the Declaration of Helsinki 2008. Informed written consent was 
obtained from participants or their families where participants were unable to give consent themselves. Seven 
care homes in South East England (510 N) participated in the study. Each care home was assessed using the 
modified Therapeutic Environment Screening Survey for nursing homes (TESS-NH) [45], to ensure the 
environments were comparable. 
 
The study was a randomised crossover design with two care homes studied concurrently (Figure. 1A) from 
September to December or January to April in 2008, 2009 and 2010. The 12-week study period began with a 
baseline week with the care homes’ own lights followed by four weeks of each lighting condition (either 4000 K 
first or 17000 K first) separated by a three week wash-out period under the care homes’ own lights.  
 
Lights were installed in communal lounges and dining rooms (n = 20) used frequently by the residents. The light 
luminaires were suspended overhead from free-standing Dexian frames, built specifically for each room (see 
graphic abstract). Light fitments were 11556 mm x 191 mm x 82 mm containing fluorescent tubes 58W TL-D 
Activiva (Philips TCS097 2 x TL-D58W HF O) for the blue-enriched 17000 K lighting and 58W TL-D lamps 
(Philips TCS097 2 x TL-D58W/451 HF O) for the control 4000 K lighting.  The two light conditions differing 
in colour temperature (17000 K or 4000 K) and spectral power distribution (Figure 1B). The intensity of the 
17000 K and 4000 K lighting was set to provide approximately 900 and 200 lux, respectively, at 1.6 m in the 
direction of gaze throughout the rooms. The irradiance and photon density was 644 µW/cm2 and 1.77 x 1015 
photons/cm2/s for the 4000 K lighting and 3422 µW/cm2 and 8.73 x 1015 photons/cm2/s for the 17000 K 
lighting. 
 
Only residents who regularly spent time in the communal rooms were eligible to take part. Across the seven care 
homes 285 people were assessed for eligibility, of these 169 did not meet the inclusion criteria (over 60 years of 
age, willing and able to give written informed consent themselves or their family, spend time each day in 
communal rooms where lights were installed) and 36 declined participation, leaving 80 residents willing and 
able to take part of which 69 were female.  
 
Study Protocol 
The study design had different levels of participation that allowed residents to complete as much as they wished 
or were capable of. Subgroups of participants answered more in depth questions about their mood, alertness and 
sleep, wore activity monitors and carried out a visual psychomotor vigilance task (PVT).  Participation levels 
are presented in Figure 2. A general health questionnaire was completed (vision, mobility) and medications 
noted for each participant at the beginning of the study. 
 
Data were collected over the same two days each week in each care home. Once a week the location of each 
participant (n = 80) and what they were doing was recorded at 09:00, 11:00, 14:00 and 16:00 h. At baseline, end 
of the wash-out (week 7) and end of each light condition (weeks 4 and 11), the mini mental state exam (MMSE) 
was administered (n = 53) [46].  Subjective sleepiness (n = 63) was assessed with the Karolinska sleepiness 
scale (KSS) [47],  and a nine-point scale ranging from 1 = very alert to 9 = very sleepy [22;48].  Three nine-
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point mood scales (calm to tense, cheerful to miserable and depressed to elated) assessed subjective mood (n = 
42) [22; 48].  These questions were asked in the same order after breakfast (09:00-11:00 h), before lunch (11:00-
13:00 h), after lunch (14:00-16:00 h) and before supper (16:00-18:00 h).  To assess anxiety and depression a 
subset of participants (n = 21) were administered the hospital anxiety and depression (HAD) scale every week 
giving a score for anxiety (HADA) and depression (HADD) [49].  At the end of each light treatment and wash-
out a subset of the study group were administered the geriatric depression scale (GDS) (n = 56) [50], and 
completed the Pittsburgh sleep quality index (PSQI) (n = 20) [51]. 
 
Seventy-three participants wore the same activity and light monitor (Actiwatch L (AWL) Cambridge 
Neurotechnology Ltd, Cambridge, UK) for the duration of the study. AWLs collected data at 1 minute epochs. 
All AWLs were calibrated for activity using equipment from the manufacturer and the light intensity lux 
readings were corrected against a calibrated  powermeter (Macam Photometrics Ltd, Livingstone, Scotland). 
Data were downloaded and checked weekly and edited prior to analysis removing periods where the AWL was 
not worn. Eleven activity variables were created for each person using parametric cosinor analysis  [52; 53] and 
non-parametric circadian rhythm analysis (NPCRA) [54]. Cosinor analysis provided values for amplitude, 
mesor and acrophase (peak time) of the rest-activity rhythm. The NPCRA created a measure of interdaily 
stability (IS) indicating the day to day variation and the intradaily variability (IV) and the fragmentation of the 
rhythm. The NPCRA gave the mean activity in the 5 least active hours (L5), the time that this period 
commenced (L5onset), mean activity during the ten most active hours (M10) and when this activity started 
(M10onset).  Measures of amplitude (AMP) and relative amplitude (RA) (L5/ M10), providing an indication of 
the strength of the rest-activity rhythm, were also calculated.  
 
Objective sleep parameters were calculated using data collected by the AWL. Specific bed times and get up 
times provided by the care staff were determined for each participant and used to analyse all sleep episodes 
across the 12 week study period. All sleep periods were assessed using the Sleepwatch software from 
Cambridge Neurotechnology Ltd. Mean weekly values were calculated for the 27 variables supplied by the 
analysis which were then subjected to statistical analysis. 
 
Psychomotor vigilance performance was measured using the visual PVT administered for 5 minutes [55],  one 
day each week, three times a day: before lunch (~09:00-11:00 h), after lunch (~14:00-16:00 h) and before 
supper (~16:00-18:00 h). The primary outputs calculated were mean reciprocal reaction time (RRT); 10% fastest 
reaction time (%FRT) and number of lapses (≥ 500 ms).    
 
An estimation of the time spent in the rooms with the experimental lights each week was made using two 
methods: observational data or light levels recorded by the AWL light monitors. Participants were observed at 
09:00, 11:00, 14:00 and 16:00 h on the same day each week and the percentage of occasions each participant 
was observed in the rooms with the experimental lights calculated.  The average time spent each day in light 
levels above a 100 lux threshold was calculated for each participant each week using the AWL data and the 
manufacturer’s software.  
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Statistical analysis 
Comparison of the light treatment regimes, 17000 K and 4000 K, was conducted for the outcome variables 
(Table 2) using SAS 9.2 (SAS Institute, Inc., Cary, NC). Linear iterative model fitting was performed, 
resulting in the use of a mixed model (PROC MIXED), without a random intercept; a 
repeated measures model was fitted with a compound symmetry covariance structure. Design 
variables entered were; light sequence (17000 K first, 4000 K first) and a nominal week identifier (#1, #2, #3, 
#4) for weekly measured outcome variables. 
 
Demographic variables considered to affect the outcome measurements were entered as covariates: age (years), 
mobility (1= fully mobile, 2 = walking stick, 3 = walking frame, 4 = wheelchair) and certain medications 
(antidepressants, antipsychotics, hypnotics, glaucoma: 1 = yes, 0 = no). Baseline scores for the relevant outcome 
variables were entered in preference to calculating and modelling changes from baseline. Two models were 
created, the only difference between them being the way the participants’ light exposure was estimated. The first 
model used the weekly observational data of their time in rooms with the lights (%) (m1 model) and the second 
used  time spent above a 100 lux threshold (m2 model). 
 
Statistically significant differences at the 5% level (p <0.05) were reported for light treatment regime, treatment 
week and (light treatment regime) x (treatment week) interaction. 
 
3. Results 
 
The care home environments were similar according to the TESS-NH (score 44.4 ± 7.0, mean ± SD; range 33 – 
52). Demographic data for the participants in each care home studied and the total participants (n = 80) are 
presented in Table 1. Forty five participants received the 4000 K lights first and 35 received the 17000 K lights 
first. Of the 80 participants, 40% were taking antidepressants, 16.3% were taking hypnotics, 12.5% were taking 
anti-psychotics and 12.5% were taking glaucoma medication. During the 12-week study eleven participants 
(13.8%) were lost to follow up (seven withdrew, one was withdrawn by the investigators and three died). The 
mean (± SD) baseline MMSE scores of the study population was 19 ± 6 (n = 62, 6.5% severe < 10: 54.8% 
moderate 10 – 20; 25.8% mild 21 - 26; 12.9% normal > 27). The number and demographics of participants 
answering each set of questions varied in size from n = 63 for the KSS to n = 17 for the PVT (Table 2; Figure 
2). 
 
None of the covariates (% time in rooms with lights (m1), time spent above 100 lux (m2), age, mobility and 
medications) were statistically significant in the modelling of the outcome variables. The two models tested, m1 
(n = 45) and m2 (n = 43), produced the same results except in one outcome: the NPCRA M10 measure. Whereas 
the m1 model showed a non-significant increase in M10 (p = 0.12), the m2 model showed a significant increase 
in daytime M10 activity during the 17000 K light condition (130 ± 80, mean ± SD) compared with the 4000 K 
light condition (126 ± 77, p = 0.03). For all the other variables both the m1 and m2 model results were the same. 
The results from the m1 model are reported in Table 3.  
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From objective actigraphic sleep analysis the blue-enriched 17000 K lights significantly increased actual wake 
time (amount of time between sleep onset and sleep offset classed as wake), actual wake percentage, activity 
score (across the whole sleep period) and activity score in wake periods with an increase in the length of the 
wake bouts (p < 0.05) thus decreasing actual sleep time, actual sleep percentage and sleep efficiency (p < 0.05). 
There were no statistically significant differences in sleep latency or fragmentation index between the light 
conditions. 
 
The 17000 K blue-enriched light significantly advanced the peak time (acrophase) of the rest-activity rhythm 
(0.5 h) compared to the control 4000 K lights (p < 0.05) using cosinor analysis. By contrast, the onset time of 
the ten most active hours (M10 onset) showed a non-significant trend to delay (0.4 h) under the 17000 K lights 
(p = 0.054). The participants showed significantly higher night-time activity in the five least active hours (L5) 
during the 17000 K lights compared to the 4000 K lights (p< 0.05). There was a significant effect of treatment 
week on daytime activity (M10) with greater activity in the last two weeks of light treatment (weeks three and 
four) compared to week two (p = 0.02) from the non-parametric circadian rhythm analysis. 
 
Subjective sleep quality as measured by the PSQI was worse after the 17000 K lights, with participants 
exhibiting a higher PSQI score compared to after the 4000 K lights (p = 0.04). Statistically significant 
differences were seen in the HADA score with the participants showing lower daytime anxiety levels during the 
17000 K blue-enriched white light compared to during the 4000 K light (p < 0.005).  
 
There were few statistically significant interactions between light treatment week and light condition for the 
outcome measures except for the calm/tense scale (light treatment week x light condition interaction, p < 0.05), 
the actual sleep and wake percentage and the mean wake score with increased wake in week 4 of the light 
treatments (p < 0.05). Participants’ self-rated calmness was significantly different in the light conditions 
between weeks two and three (more calm in week 3) and participants under the 4000 K condition were more 
tense during week three compared to week four.  
 
No significant differences were seen between the light conditions for the PVT variables: reciprocal reaction time 
(RRT); 10% fastest reaction time and lapses (≥ 500 msec) (Table 3). The time of day that the PVT was 
administered significantly affected the mean RRT and the number of lapses (p < 0.05);  participants (n = 17) had 
fewest lapses in the morning (12.0 ± 10.3), and most lapses after lunch (13.7 ± 11) with slower reaction times in 
the morning (RRT 2.5 ± 0.9) and faster reaction times in the afternoon (RRT 2.4 ± 0.9) .  
 
4. Discussion 
The current study investigated the effect of overhead blue-enriched white lighting on older people, without 
diagnosed dementia, living in care homes, the majority (65%) of those classified as having  moderate cognitive 
impairment giving MMSE scores of 15 and above. Unlike previous studies [40; 56-58], participants in the 
current study were free to enter and leave the communal areas housing the experimental lights whenever they 
wished allowing for the natural behaviour of residents.  Moreover, the participants were independently living 
and free to leave and enter the care home. Some, but not all, previous studies have reported that increasing light 
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levels in residential care homes can lead to strengthening of the rest-activity rhythm and better sleep in older 
people [17;37; 38; 40; 58-60]. The participants in these studies were diagnosed as suffering from dementia and 
the study protocols required individuals to either sit in front of bright white light boxes, of varying colour 
temperatures, for set hours of the day or under bright overhead lighting switched on for different periods of the 
day. Owing to the different nature of each care home setting and how our study was arranged to allow the 
residents to be able to carry on their normal day to day lives, we recognise that there are limitations to this study. 
However, these limitations are important to acknowledge and address as the previous studies controlling 
participants’ behaviour are less practical to instigate in a normal care home setting.  
  
Indoor lighting levels in care homes for older people are reported to be low and considered insufficient to meet 
the European standard [61; 62]. In agreement with these reports, existing lighting levels in the care homes 
participating in the current study were also low (51 ± 9 lux) [63].  
 
Residents exhibited increased activity in the 17000K lights during both the day and night (M10, L5 and mean 
activity score). This activating effect of light on activity levels is in agreement with some of the previous studies 
in demented subjects [40; 42; 54; 64]. Night-time activity, assessed during the five least active hours (NPCRA 
L5), was significantly higher and sleep efficiency and actual sleep time significantly lower during the 17000 K 
light condition. This finding implies increased night-time agitation during the 17000 K light period. Previous 
light studies have also reported increased agitation at night from caregivers’ observational data [65], although 
specific effects on objective night-time activity (L5) have not previously been reported.  Blue-enriched or white 
light have shown no effect on sleep efficiency of older people [66]. The well-known alerting effects of light [18] 
especially blue light, may explain the increased activity measured during the day and night in the 17000 K blue-
enriched light condition.   
 
The acrophase (peak time) of the rest-activity rhythm occurred significantly earlier under the 17000 K lights 
than under the 4000 K lights which could be explained by the participants receiving extra brighter blue-enriched 
light in the earlier part of the day corresponding to the phase-advance portion of the phase response curve for 
light [15; 67].   Care home routines meant that participants usually retired to their own bedrooms (with no 
experimental lights) after the evening meal thus reducing their bright light exposure in the later (phase-delaying) 
part of the day. From NPCRA analysis the beginning of the 10 h with greatest activity (M10 onset) occurred 
slightly, but not significantly, later with the 17000 K light (10.00 h ± 2.5) compared to the 4000 K light (9.6 h ± 
2.7). This finding would appear to contradict the observed advance in the acrophase of the rest-activity rhythm, 
however, this could be due to an overall increase in activity levels across the whole day thus extending the 
active period whilst acrophase cosinor analysis is restricted to identifying the time of maximum activity levels. 
 
Subjective sleep quality as measured by the PSQI was poorer after four weeks of 17000 K light than after 4000 
K lighting.  This finding may be related to the objective findings of increased night-time activity, lower sleep 
efficiency and lower actual sleep time during the 17000 K light condition. A positive effect of 10000 lux light 
for 30 minutes a day for 30 days was seen in PSQI scores of care home residents with mean PSQI scores 
changing from 12.8 ± 4.26 at baseline to 3.95 ± 1.75 after treatment [68]. Unfortunately in the current study the 
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number of participants who completed the PSQI was relatively low (25%) owing to the complexity of the 
questionnaire for these older care home residents. The use of the PSQI questionnaire in this study population 
may not be appropriate and use of a simpler sleep scale is recommended for future studies.  A previous study 
investigating the effect of light on sleep in older people living in the community found that the PSQI and the 
objective sleep measures did not correlate [69].  
 
Self-rated anxiety (HADA) was significantly different between the lighting conditions with reduced anxiety in 
the daytime during the 17000 K light intervention. This finding is in agreement with a study by Kobayashi et 
al.[70]  in which lower anxiety was reported in healthy older people during bright light treatment.  Further work 
looking at additional anxiety measurements during light studies would be useful to confirm our finding.  
 
Apart from an effect on self-rated anxiety, bright blue-enriched light had no significant effect on other self-rated 
mood parameters (depression, cheerfulness, calmness, alertness) or performance (PVT). It should be noted that 
in the current study participants were not forced to be exposed to the experimental lights during the mood and 
alertness assessments thus the well-known acute effect of lighting on mood and alertness [18; 19; 22; 25; 27; 66; 
71], may not have been captured. The subjective mood and sleep questionnaires used in the current study may 
also have been too blunt an instrument to discriminate small changes in mood, alertness and sleep quality in this 
older study population, although changes were seen in office workers [27], and in a population of nursing home 
residents with [38] and without dementia [72]. In the former study, however, care givers evaluated the 
participants’ mood and behaviour, whereas in the current study participants responded themselves which may 
well account for the discrepant results.  
 
Although the performance measures (PVT) showed no difference between the lighting conditions, a time of day 
effect was observed in reaction time and number of lapses, as has been previously reported [73] .  It is possible 
that with the current study population reaction time was slow due to physical constraints which allowed no 
measurable improvement during the different light conditions. A previous study of older people suggested that 
this study population is less likely to show a change in PVT performance with different amounts of sleep [74].  
 
It is not known whether light may impact differentially in men and women. In this study the gender imbalance 
(69 female, 11 male) makes gender comparison impractical. However, it is reflective of the older population as 
women live on average longer than men, and although the differential is decreasing, it is inevitable that 
residential care homes for older individuals will have a preponderance of females.  
 
Installation of the same high colour temperature (17000 K) blue-enriched light sources in the workplace has 
been reported to improve self-reported alertness, mood and irritability in office workers compared to 4000 K 
white light [27; 30].  In Antarctica 17000 K blue-enriched light throughout the wake period advanced the 
circadian system (as assessed by the urinary melatonin metabolite, 6-sulphatoxymelatonin) accompanied by 
earlier actigraphic sleep onset and shorter sleep latency during the winter [28].  Also in Antarctica normal 
fluorescent light of 100-300 lux showed a significant delay in melatonin onset compared to blue-enriched white 
light with no difference in rest-activity rhythms by NCPRA under the two light conditions [29].  Similarly, a 
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recent study reported cognitive improvements using an assessment of cognitive function and a profile of mood 
states with 30 minutes of blue LED light (400 lux) each day compared to red light in older people in long term 
care [75].  Despite these positive effects of blue or blue-enriched light, in the current study only one of the mood 
variables showed a significant difference between the two light conditions. There are several possible 
explanations for this. Firstly the experimental light was set at around 900 lux which may have been too low to 
observe an effect whereas other studies have used higher light intensities (e.g. 3000 lux [69]). The light 
interventions were only for 4 weeks which may not be sufficient time to elicit a permanent change in behaviour 
in this study population. Based on a previous study [38], use of bright light over a longer time (2-3 years) might 
have given more substantive results.  Finally, the questionnaires and tests used in the current study may be 
inappropriate to identify small changes in mood and behaviour given the age-related reduced cognitive ability of 
the participants. 
 
For future work in order to increase the effectiveness of the lights, installing lights in the participants’ bedrooms 
could be considered if ethical considerations and cost would allow, however, this needs to be balanced against 
light’s ability to increase alertness before bedtime and delay sleep time [76; 77].  
 
Blue-enriched polychromatic light has now been tested in a number of settings [27-30], but caution should be 
applied to the findings, as in some cases, such as the study of older people reported here, the effects appear 
small and mixed. Based on this work it is important to further characterise the risks and benefits of 17000 K 
blue-enriched light prior to this lighting being applied permanently in care homes for older people. 
12 
 
Conflict of interest: There are no financial, personal, potential conflicts of interest in the conduct of the study 
or in the manuscript development. Although Philips Lighting supplied the light fitments, they had no part in the 
design of the protocol nor in the analysis of the data. 
Prof. Skene and Dr Middleton are co-directors of Stockgrand Ltd and Prof. Skene has in the past received 
research grant support from Philips. Dr. Luc Schlangen is an employee of Philips Research.  
Acknowledgements 
This work was supported by the Cross-Council New Dynamics of Ageing (NDA) initiative (Grant number RES-
339-25-0009). 
We thank Philips Lighting, The Netherlands for providing the light fitments, the Faculty workshop staff at the 
University of Surrey for building the Dexian frames for the lights, the care home staff and residents for their 
help and participation in the study and Daniel Barrett and Dr Rebecca Luff for assistance in collecting the data. 
D.J.S. is a Royal Society Wolfson Research Merit Award holder. 
 
Author Contributions: Study concept and design: Debra J. Skene, Benita Middleton. Acquisition of subjects 
and/or data Samantha Hopkins, Peter Lloyd Morgan, Benita Middleton,. Analysis and interpretation of data: 
Samantha Hopkins, Peter Lloyd Morgan, Peter Williams, Debra J. Skene, Benita Middleton. Preparation of 
manuscript: Samantha Hopkins, Peter Lloyd Morgan, Luc J.M. Schlangen, Peter Williams, Debra J. Skene, 
Benita Middleton.
13 
 
References 
[1] Bliwise DL. Sleep in normal aging and dementia. Sleep 16(1): 40-81(1993). 
[2] Neikrug AB, Ancoli-Israel S. Sleep disorders in the older adult - a mini-review. Gerontology 56(2): 181-9 
(2010). 
[3] Van Someren EJ. Circadian and sleep disturbances in the elderly. Exp Gerontol 35(9-10): 1229-37 (2000). 
[4] Mishima K, Okawa M, Shimizu T, Hishikawa Y. Diminished melatonin secretion in the elderly caused by 
insufficient environmental illumination. J Clin Endocrinol Metab 86(1): 129-34 (2001). 
[5] Czeisler CA, Dumont M, Duffy JF, Steinberg JD, Richardson GS, Brown EN, et al. Association of sleep-
wake habits in older people with changes in output of circadian pacemaker. Lancet 340: 933-6 (1992). 
[6] Duffy JF, Czeisler CA. Age-related change in the relationship between circadian period, circadian phase, and 
diurnal preference in humans. Neurosci Lett 318(3): 117-20 (2002). 
[7] Munch M, Knoblauch V, Blatter K, Wirz-Justice A, Cajochen C. Is homeostatic sleep regulation under low 
sleep pressure modified by age? Sleep 30(6): 781-92 (2007). 
[8] Blackwell T, Yaffe K, Ancoli-Israel S, Schneider JL, Cauley JA, Hillier TA, et al. Poor sleep is associated 
with impaired cognitive function in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med 
Sci 61(4): 405-10 (2006). 
[9] Stone KL, Ancoli-Israel S, Blackwell T, Ensrud KE, Cauley JA, Redline S, et al. Actigraphy-measured sleep 
characteristics and risk of falls in older women. Arch Intern Med 168(16): 1768-75 (2008). 
[10] Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG. Sleep complaints among 
elderly persons: an epidemiologic study of three communities. Sleep 18(6): 425-32 (1995). 
[11] Oosterman JM, van Someren EJ, Vogels RL, Van Harten B, Scherder EJ. Fragmentation of the rest-activity 
rhythm correlates with age-related cognitive deficits. J Sleep Res 18(1): 129-35 (2009). 
[12] Cajochen C, Munch M, Knoblauch V, Blatter K, Wirz-Justice A. Age-related changes in the circadian and 
homeostatic regulation of human sleep. Chronobiol Int 23(1-2): 461-74 (2006). 
[13] Dijk DJ, Duffy JF, Czeisler CA. Contribution of circadian physiology and sleep homeostasis to age-related 
changes in human sleep. Chronobiol Int 17(3): 285-311(2000). 
[14] Dijk DJ. Sleep of aging women and men: back to basics. Sleep 29(1): 12-3 (2006). 
[15] Czeisler CA, Allan JS, Strogatz SH, Ronda JM, Sanchez R, Rios CD, et al. Bright light resets the human 
circadian pacemaker independent of the timing of the sleep-wake cycle. Science 233(4764): 667-71 (1986). 
[16] Van Someren EJ, Kessler A, Mirmiran M, Swaab DF. Indirect bright light improves circadian rest-activity 
rhythm disturbances in demented patients. Biol Psychiatry 41(9): 955-63 (1997). 
[17] Chong MS, Tan KT, Tay L, Wong YM, Ancoli-Israel S. Bright light therapy as part of a multicomponent 
management program improves sleep and functional outcomes in delirious older hospitalized adults. Clinical 
Interventions Aging 8: 565-72 (2013). 
[18] Cajochen C, Zeitzer JM, Czeisler CA, Dijk DJ. Dose-response relationship for light intensity and ocular 
and electroencephalographic correlates of human alertness. Behav Brain Res 115(1): 75-83 (2000). 
[19] Phipps-Nelson J, Redman JR, Dijk DJ, Rajaratnam SM. Daytime exposure to bright light, as compared to 
dim light, decreases sleepiness and improves psychomotor vigilance performance. Sleep 26(6): 695-700 (2003). 
14 
 
[20] Chang AM, Santhi N, St Hilaire M, Gronfier C, Bradstreet DS, Duffy JF, et al. Human responses to bright 
light of different durations. J Physiol 590(Pt 13): 3103-12 (2012). 
[21] Ruger M, Gordijn MC, Beersma DG, de Vries B, Daan S. Time-of-day-dependent effects of bright light 
exposure on human psychophysiology: comparison of daytime and nighttime exposure. Am J Physiol 290(5): 
R1413-20 (2006). 
[22] Sletten TL, Revell VL, Middleton B, Lederle KA, Skene DJ. Age-related changes in acute and phase-
advancing responses to monochromatic light. J Biol Rhythms 24(1): 73-84 (2009). 
[23] Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, et al. Action spectrum for 
melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 21(16): 6405-12 
(2001). 
[24] Thapan K, Arendt J, Skene DJ. An action spectrum for melatonin suppression: evidence for a novel non-
rod, non-cone photoreceptor system in humans. J Physiol 535(Pt 1): 261-7 (2001). 
[25] Cajochen C, Munch M, Kobialka S, Krauchi K, Steiner R, Oelhafen P, et al. High sensitivity of human 
melatonin, alertness, thermoregulation, and heart rate to short wavelength light. J Clin Endocrinol Metab 90(3): 
1311-6 (2005). 
[26] Chellappa SL, Steiner R, Oelhafen P, Lang D, Gotz T, Krebs J, et al. Acute exposure to evening blue-
enriched light impacts on human sleep. J Sleep Res 22(5): 573-80 (2013). 
[27] Viola AU, James LM, Schlangen LJ, Dijk DJ. Blue-enriched white light in the workplace improves self-
reported alertness, performance and sleep quality. Scand J Work Environ Health 34(4): 297-306 (2008). 
[28] Mottram V, Middleton B, Williams P, Arendt J. The impact of bright artificial white and 'blue-enriched' 
light on sleep and circadian phase during the polar winter. J Sleep Res 20(1 Pt 2): 154-61 (2011). 
[29] Najjar RP, Wolf L, Taillard J, Schlangen LJM, Salam A, Cajochen C, et al. Chronic artificial blue-enriched 
white light is an effective countermeasure to delayed circadian phase and neurobehavioral decrements. PloS one 
9(7) 2014). 
[30] Vetter C, Juda M, Lang D, Wojtysiak A, Roenneberg T. Blue-enriched office light competes with natural 
light as a zeitgeber. Scand J Work Environ Health 37(5): 437-45 (2011). 
[31] Revell VL, Skene DJ. Impact of age on human non-visual responses to light. Sleep Biol Rhythms 8: 84–94 
(2010). 
[32] Haegerstrom-Portnoy G. Short wavelength-sensitive-cone sensitivity loss with aging: a protective role for 
the macular pigment? J Opt Sci Am A 5: 2140-44 (1988). 
[33] Curcio CN, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic: evidence for 
selective vulnerability of rods in the central retina. Invest Ophthalmol Vis Sci 34: 3278-96 (1993). 
[34] Duffy JF, Zeitzer JM, Czeisler CA. Decreased sensitivity to phase-delaying effects of moderate intensity 
light in older subjects. Neurobiol Aging 28(5): 799-807 (2007). 
[35] Herljevic M, Middleton B, Thapan K, Skene DJ. Light-induced melatonin suppression: age-related 
reduction in response to short wavelength light. Exp Gerontol 40(3): 237-42 (2005). 
[36] Najjar RP, Chiquet C, Teikari P, Cornut PL, Claustrat B, Denis P, et al. Aging of non-visual spectral 
sensitivity to light in humans: Compensatory mechanisms? PloS one 9(1) (2014). 
[37] Figueiro MG, Plitnick BA, Lok A, Jones GE, Higgins P, Hornick TR, et al. Tailored lighting intervention 
improves measures of sleep, depression, and agitation in persons with Alzheimer's disease and related dementia 
living in long-term care facilities. Clinical Interventions Aging 9: 1527-37 (2014). 
15 
 
[38] Riemersma-van der Lek RF, Swaab DF, Twisk J, Hol EM, Hoogendijk WJ, Van Someren EJ. Effect of 
bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a 
randomized controlled trial. JAMA 299(22): 2642-55 (2008). 
[39] Alessi CA, Martin JL, Webber AP, Cynthia Kim E, Harker JO, Josephson KR. Randomized, controlled 
trial of a nonpharmacological intervention to improve abnormal sleep/wake patterns in nursing home residents. J 
Am Geriatr Soc 53(5): 803-10 (2005). 
[40] Ancoli-Israel S, Martin JL, Kripke DF, Marler M, Klauber MR. Effect of light treatment on sleep and 
circadian rhythms in demented nursing home patients. J Am Geriatr Soc 50(2): 282-9 (2002). 
[41] Colenda CC, Cohen W, McCall WV, Rosenquist PB. Phototherapy for patients with Alzheimer disease 
with disturbed sleep patterns: results of a community-based pilot study. Alzheimer Dis Assoc Disord 11(3): 175-
8 (1997). 
[42] Ouslander JG, Connell BR, Bliwise DL, Endeshaw Y, Griffiths P, Schnelle JF. A nonpharmacological 
intervention to improve sleep in nursing home patients: results of a controlled clinical trial. J Am Geriatr Soc 
54(1): 38-47 (2006). 
[43] Murphy PJ, Campbell SS. Enhanced performance in elderly subjects following bright light treatment of 
sleep maintenance insomnia. Journal of sleep research 5(3): 165-72 (1996). 
[44] Montgomery P, Dennis J. Bright light therapy for sleep problems in adults aged 60+. The Cochrane 
Database of Systematic Reviews(2): CD003403 (2002). 
[45] Sloane PD, Mitchell CM, Weisman G, Zimmerman S, Foley KM, Lynn M, et al. The Therapeutic 
Environment Screening Survey for Nursing Homes (TESS-NH): an observational instrument for assessing the 
physical environment of institutional settings for persons with dementia. J Gerontol 57(2): S69-78.(2002). 
[46] Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive 
state of patients for the clinician. J Psychiatr Res 12(3): 189-98 (1975). 
[47] Akerstedt T, Gillberg M. Subjective and objective sleepiness in the active individual. Int J Neurosci 52(1-
2): 29-37 (1990). 
[48] Lockley SW, Dijk DJ, Kosti O, Skene DJ, Arendt J. Alertness, mood and performance rhythm disturbances 
associated with circadian sleep disorders in the blind. J Sleep Res 17(2): 207-16 (2008). 
[49] Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica 
67(6): 361-70 (1983). 
[50] Sheikh JIY, J. A. . Geriatric depression scale (GDS): Recent evidence and development of a shorter 
version. Clin Gerontologist 5(1-2): 165-73 (1986). 
[51] Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a 
new instrument for psychiatric practice and research. Psychiatry Res 28(2): 193-213 (1989). 
[52] Minors DS, Waterhouse JM. Mathematical and statistical analysis of circadian rhythms. 
Psychoneuroendocrinology 13(6): 443-64 (1988). 
[53] Nelson W, Tong YL, Lee JK, Halberg F. Methods for cosinor-rhythmometry. Chronobiologia 6(4): 305-23 
(1979). 
[54] Van Someren EJ, Swaab DF, Colenda CC, Cohen W, McCall WV, Rosenquist PB. Bright light therapy: 
improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric 
methods. Chronobiol Int 16(4): 505-18 (1999). 
16 
 
[55] Roach GD, Dawson D, Lamond N. Can a shorter psychomotor vigilance task be used as a reasonable 
substitute for the ten-minute psychomotor vigilance task? Chronobiol Int 23(6): 1379-87 (2006). 
[56] Yamadera H, Ito T, Suzuki H, Asayama K, Ito R, Endo S. Effects of bright light on cognitive and sleep-
wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry Clin Neurosci 54(3): 352-3 
(2000). 
[57] Fetveit A, Skjerve A, Bjorvatn B. Bright light treatment improves sleep in institutionalised elderly--an open 
trial. Int J Geriatr Psych 18(6): 520-6 (2003). 
[58] Fetveit A, Bjorvatn B. The effects of bright-light therapy on actigraphical measured sleep last for several 
weeks post-treatment. A study in a nursing home population. J Sleep Res13(2): 153-8 (2004). 
[59] Van Someren EJW, Kessler A, Mirmiran M, Swaab DF. Indirect bright light improves circadian rest-
activity rhythm disturbances in demented patients. Biol Psychiatry 41(9): 955-63 (1997). 
[60] Fetveit A, Bjorvatn B. Bright-light treatment reduces actigraphic-measured daytime sleep in nursing home 
patients with dementia: a pilot study. Am J Geriatr Psychiatry 13(5): 420-3 (2005). 
[61] Shochat T, Martin J, Marler M, Ancoli-Israel S. Illumination levels in nursing home patients: effects on 
sleep and activity rhythms. J Sleep Res 9(4): 373-9 (2000). 
[62] De Lepeleire J, Bouwen A, De Coninck L, Buntinx F. Insufficient lighting in nursing homes. JAMDA 8(5): 
314-7 (2007). 
[63] Morgan PL. The light environment in care homes: resident light exposure and the effects on rest-activity 
rhythms. PhD. University of Surrey (2011). 
[64] Dowling GA, Burr RL, Van Someren EJ, Hubbard EM, Luxenberg JS, Mastick J, et al. Melatonin and 
bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am 
Geriatr Soc 56(2): 239-46 (2008). 
[65] Barrick AL, Sloane PD, Williams CS, Mitchell CM, Connell BR, Wood W, et al. Impact of ambient bright 
light on agitation in dementia. Int J Geriatr Psychiatry 25(10): 1013-21 (2010). 
[66] Munch M, Scheuermaier KD, Zhang R, Dunne SP, Guzik AM, Silva EJ, et al. Effects on subjective and 
objective alertness and sleep in response to evening light exposure in older subjects. Behav Brain Res 224(2): 
272-8 (2011). 
[67] Khalsa SB, Jewett ME, Cajochen C, Czeisler CA. A phase response curve to single bright light pulses in 
human subjects. J Physiol 549(Pt 3): 945-52 (2003). 
[68] Akhar I, Akdemir N. The effect of light therapy on the sleep quality of the elderly. AJAN 31(2): 31-38 
(2014). 
[69] Hood B, Bruck D, Kennedy G. Determinants of sleep quality in the healthy aged: the role of physical, 
psychological, circadian and naturalistic light variables. Age Ageing 33(2): 159-65 (2004). 
[70] Kobayashi R, Kohsaka M, Fukuda N, Sakakibara S, Honma H, Koyama T. Effects of morning bright light 
on sleep in healthy elderly women. Psychiatry Clin Neurosci 53(2): 237-8 (1999). 
[71] LeGates TA, Fernandez DC, Hattar S. Light as a central modulator of circadian rhythms, sleep and affect. 
Nat Rev Neurosci 15(7): 443-54 (2014). 
[72] Wu MC, Sung HC, Lee WL, Smith GD. The effects of light therapy on depression and sleep disruption in 
older adults in a long-term care facility. Int J Nursing Prac on-line April (2014). 
17 
 
[73] Van Dongen HP, Dinges DF. Sleep, circadian rhythms, and psychomotor vigilance. Clinics Sports Med 
24(2): 237-49 (2005). 
[74] Blatter K, Graw P, Munch M, Knoblauch V, Wirz-Justice A, Cajochen C. Gender and age differences in 
psychomotor vigilance performance under differential sleep pressure conditions. Behav Brain Res 168(2): 312-7 
(2006). 
[75] Royer M, Ballentine NH, Eslinger PJ, Houser K, Mistrick R, Behr R, et al. Light therapy for seniors in long 
term care. JAMDA 13(2): 100-2 (2012). 
[76] Santhi N, Thorne HC, van der Veen DR, Johnsen S, Mills SL, Hommes V, et al. The spectral composition 
of evening light and individual differences in the suppression of melatonin and delay of sleep in humans. J 
Pineal Res 53(1): 47-59  (2012). 
[77] Wahnschaffe A, Haedel S, Rodenbeck A, Stoll C, Rudolph H, Kozakov R, et al. Out of the lab and into the 
bathroom: evening short-term exposure to conventional light suppresses melatonin and increases alertness 
perception. Int J Mol Sci 14(2): 2573-89 (2013). 
 
  
18 
 
Table 1. Baseline Demographics for All Participants 
 
 
Care 
home n Time of year Owner of care home 
Number of beds  
in care home 
 Age (yrs) 
(mean ± SD) male: female 
1 11 Sept. 2008 Local authority 38 84.9 (6.0) 1:10 
 
2 9 Sept. 2008 Local authority 38 84.6 (9.9) 2:7 
4 13 Jan. 2009 Private company 43 87.6 (5.9) 0:13 
5 19 Sept. 2009 Private company 76 84.1 (7.2) 5:14 
6 10 Sept. 2009 Private company 78 87.2 (4.5) 0:10 
7 7 Jan. 2010 Private company 58 85.4 (7.5) 1:6 
8 11 Jan. 2010 Private company 28 87.4 (11.3) 2:9 
Total 80       85.8 (7.5) 11:69 
 
 
  
Weeks
Care home 1
1 2 3 4 5 6 7 8 9 10 11 12
Care home 2
1 2 3 4 5 6 7 8 9 10 11 12
base line (care 
home lights) ~ 
60 lux
4000 K light 
~200 lux
17000 K light 
~1000 lux
wash out (care 
home lights) ~ 
60 lux
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Table 2.  Demographics of the Participants Included at Completion of Each Outcome Measure 
 
Outcome measure Number of 
participants 
Age 
 (mean 
years ± SD) 
Male: 
female 
Mean MMSE score 
(mean ± SD) (n) 
Rest-activity     
Cosinor amplitude, acrophase, 
mesor 
34 84.8 ±8.1 5:29 19.3 ± 6.8 (30) 
NPCRA 
All parameters 
45 84.8 ±7.6 5:40 19.6 ± 6.6 (38) 
Actigraphic sleep analysis    
All parameters 47 85.2 ± 7.7 5:42 19.6 ± 6.5 (40) 
Mood and sleep     
Alert / Sleepy     
Calm / Tense 42 86.6 ±7.4 4:38 18.9 ± 5.6 (36) 
Cheerful / Miserable     
Depressed / Elated     
KSS 63 86.0 ±7.4 7:56 19.0 ± 5.7 (57) 
GDS 56 86.6 ±6.6 7:49 19.3 ± 5.7 (52) 
HAD 21 86.2 ±7.4 4:17 23.9 ± 4.6 (19) 
PSQI 20 86.5 ±7.7 3:17 23.8 ± 4.6 (17) 
Performance     
PVT lapses, mean RRT,  
10% F RT 
17 85.2 ±7.8 3:14 23.6 ± 5.7 (17) 
     
GDS = Geriatric Depression Scale; HAD = Hospital Anxiety & Depression Scale; KSS = Karolinska Sleepiness 
Scale; NPCRA = Non parametric circadian rhythm analysis; PSQI = Pittsburgh Sleep Quality Index;  
PVT = Psychomotor Vigilance Task; RRT = Reciprocal Reaction Time; 10% FRT = 10% Fastest Reaction. 
Time. 
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Table 3. Outcome Measures Estimated from the Repeated Measures Analysis of Variance m1 Model 
(mean ± SD).  
 
  Light Condition   
Outcome measure  n    17000 K     4000 K   P 
Rest-activity   
Cosinor amplitude 34 2955 ± 1844 2924 ± 1821 0.58 
Cosinor acrophase (dec. h) 34 14.7 ± 2.5 15.2 ± 2.6 0.04* 
Cosinor mesor 34 4490 ± 2539 4416 ± 2397 0.9 
IS 45 0.5 ± 0.1 0.5 ± 0.1 0.61 
IV 45 1.3 ± 0.3 1.3 ± 0.3 0.95 
L5 45 27.4 ± 30.1 24.9 ± 23.4 0.04* 
L5 onset (h) 45 24.3 ± 2.1 24.0 ± 1.9 0.13 
M10 45 132 ± 81 128 ± 76 0.12 
M10 onset (h) 45 10.0 ± 2.5 9.6 ± 2.7 0.05 
Amplitude 45 105 ± 63 103 ± 63 0.43 
Relative amplitude 45 0.7 ± 0.2 0.7 ± 0.2 0.63 
Actigraphic sleep analysis         
Actual sleep time (dec h) 47 8.1 ± 0.2 8.3 ± 0.2 0.04* 
Actual sleep % 47 81.0 ± 2.0  82.1 ± 2.0   0.03*  
Actual wake time (dec h) 47  1.8 ± 1.1  1.7 ± 0.9   0.02*  
Actual wake % 47 19.0 ± 11.4  17.9 ± 9.8   0.03*  
Sleep latency (dec h) 47 0.64 ± 0.43 0.61 ± 0.34 0.25 
Sleep efficiency % 47 74.3 ± 12.9 75.6 ± 11.5 0.045* 
Mean activity score  47  39.2 ±  42.4 34.5 ± 32.1  0.004**  
Mean score in wake periods 47  131.8 ± 93.9  121 ± 81  0.002**  
Mean wake bout time (dec h) 47  0.08 ± 0.05  0.07 ± 0.03  <0.001***  
Mean wake score 47  119.0 ± 75.8  112.5 ± 68.7  0.007**  
Fragmentation index 47  54.0 ± 17.0  52.7 ± 16.8  0.18  
Mood and Sleep         
Alert/ Sleepy 42 4.4 ± 1.5 4.4 ± 1.3 0.66 
Calm / Tense 42 3.7 ± 1.3 3.7 ± 1.2 0.62 
Cheerful / Miserable 42 4.0 ± 1.3 3.9 ± 1.2 0.87 
Depressed / Elated 42 5.7 ± 1.2 5.6 ± 1.2 0.26 
KSS 63 4.0 ± 1.5 4.1 ± 1.4 0.69 
GDS 56 4.4 ± 2.9 4.0 ± 3.3 0.42 
HADA 21 4.5 ± 2.5 4.6 ± 2.7 0.004** 
HADD 21 3.7 ± 2.4 4.0 ± 2.4 0.53 
PSQI 20 6.6 ± 2.9 5.6 ± 2.5 0.04* 
Performance         
PVT mean RRT 17 2.5 ± 0.9 2.5 ± 0.9 0.71 
PVT lapses (≥ 500 ms) 17 12.3 ± 9.3 13.2 ± 10.0 0.25 
PVT 10% FRT 17 308 ± 139.7 315.0 ± 12.7 0.25 
Statistical significance set at p < 0.05 
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GDS = Geriatric Depression Scale; HADA = Hospital Anxiety & Depression Scale Anxiety component; HADD 
= Hospital Anxiety & Depression Scale Depression component;  IS = Interadaily Stability; IV = Intradaily 
Variability; KSS = Karolinska Sleepiness Scale; L5 = average activity during 5 h least active; L5 Onset = start 
time of 5 h with least activity; M10 = average activity in 10 consecutive most active hours; M10 Onset = start 
time of 10 h with most activity; NPCRA = Non parametric circadian rhythm analysis; PSQI = Pittsburgh Sleep 
Quality Index; PVT = Psychomotor Vigilance Task; RRT = Reciprocal Reaction Time; 10% FRT = 10% Fastest 
Reaction Time. 
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Figure legends 
 
Figure 1.  
A. Diagram of light intervention trial design with two care homes being 
studied concurrently. One baseline week (BL) was followed by four weeks of each light  
condition (either 4000 K first or 17000 K first) separated by three weeks washout. 
Light illuminance levels (lux, mean ± SEM) were recorded at 1.6 m in the direction of gaze. 
B. Spectral power distribution of the polychromatic fluorescent lighting installed  
in the care home communal rooms (17000 K lighting, solid dark line; 4000 K lighting, dotted line). Details of 
the lights (irradiance, photon density) are in the text. 
 
Figure 2.  
Flow chart of the participants included in the study and the outcomes measured. 
GDS = Geriatric Depression Scale; HAD = Hospital Anxiety & Depression Scale;  
KSS = Karolinska Sleepiness Scale; NPCRA = Non parametric circadian rhythm analysis; PSQI = Pittsburgh 
Sleep Quality Index; PVT = Psychomotor Vigilance Task. 
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Figure 2 
 
 
Total number of 
residents
n = 285
Met inclusion 
criteria
n = 116
Did not meet 
inclusion criteria 
n = 169
Agreed to take part
n = 80
Completed study
n = 69
Declined participation 
n = 36
Activity
cosinor
n = 34
Activity
NPCRA 
n = 45
PSQI
n = 20
Mood
scales
n = 42
KSS
n = 63
PVT
n = 17
GDS
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HAD
n = 21
Actigraphic
sleep
n = 47
